M E 33 (Erlotinib Hydrochloride 150 mg)
Pill with imprint M E 33 is White, Round and has been identified as Erlotinib Hydrochloride 150 mg. It is supplied by Mylan Pharmaceuticals Inc..
Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M E 33
Erlotinib Hydrochloride
- Imprint
- M E 33
- Strength
- 150 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Egfr inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-7133
Related Images for "M E 33"
More about erlotinib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: EGFR inhibitors
Consumer resources
- Other brands
- Tarceva
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.